We just received data on a new analyst forecast for $ROIV. Samantha Semenkow from Citigroup set a price target of 35.0 for ROIV.
To track analyst ratings and price targets for $ROIV, check out Quiver Quantitative's $ROIV forecast page.
Should you buy $ROIV?
Some analysts are better than others. To view the past performance of Citigroup, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$ROIV Price Targets
Multiple analysts have issued price targets for $ROIV recently. We have seen 8 analysts offer price targets for $ROIV in the last 6 months, with a median target of $31.0.
Here are some recent targets:
- Douglas Tsao from HC Wainwright & Co. set a target price of $33.0 on 02/10/2026
- Samantha Semenkow from Citigroup set a target price of $35.0 on 02/10/2026
- Yatin Suneja from Guggenheim set a target price of $30.0 on 02/09/2026
- Corinne Jenkins from Goldman Sachs set a target price of $33.0 on 12/15/2025
- David Risinger from Leerink Partners set a target price of $32.0 on 12/15/2025
- Brian Cheng from JP Morgan set a target price of $20.0 on 09/18/2025
- Chi Fong from B of A Securities set a target price of $16.5 on 09/18/2025
$ROIV Insider Trading Activity
$ROIV insiders have traded $ROIV stock on the open market 63 times in the past 6 months. Of those trades, 1 have been purchases and 62 have been sales.
Here’s a breakdown of recent trading of $ROIV stock by insiders over the last 6 months:
- VIVEK RAMASWAMY has made 0 purchases and 9 sales selling 6,734,097 shares for an estimated $128,337,673.
- ERIC VENKER (President & Immunovant CEO) has made 0 purchases and 18 sales selling 4,328,209 shares for an estimated $72,771,178.
- KEITH S MANCHESTER has made 0 purchases and 9 sales selling 2,994,614 shares for an estimated $65,369,713.
- FINANCIAL LP QVT has made 0 purchases and 9 sales selling 2,994,614 shares for an estimated $65,369,713.
- DANIEL ALLEN GOLD has made 0 purchases and 9 sales selling 2,994,614 shares for an estimated $65,369,713.
- MATTHEW GLINE (CEO) has made 1 purchase buying 3,315 shares for an estimated $49,957 and 3 sales selling 1,740,000 shares for an estimated $37,723,200.
- MAYUKH SUKHATME (President & CIO) has made 0 purchases and 3 sales selling 1,357,699 shares for an estimated $29,522,028.
- RICHARD PULIK (CFO) has made 0 purchases and 2 sales selling 406,731 shares for an estimated $9,122,307.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ROIV Congressional Stock Trading
Members of Congress have traded $ROIV stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ROIV stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ROIV Hedge Fund Activity
We have seen 231 institutional investors add shares of $ROIV stock to their portfolio, and 148 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SB INVESTMENT ADVISERS (UK) LTD removed 19,637,525 shares (-32.8%) from their portfolio in Q3 2025, for an estimated $297,115,753
- UBS GROUP AG added 15,645,836 shares (+570.0%) to their portfolio in Q4 2025, for an estimated $339,514,641
- VIKING GLOBAL INVESTORS LP removed 10,642,948 shares (-31.1%) from their portfolio in Q3 2025, for an estimated $161,027,803
- GOLDMAN SACHS GROUP INC added 8,621,567 shares (+365.2%) to their portfolio in Q4 2025, for an estimated $187,088,003
- ASSENAGON ASSET MANAGEMENT S.A. added 6,877,348 shares (+11507.5%) to their portfolio in Q4 2025, for an estimated $149,238,451
- FMR LLC added 5,257,703 shares (+9.5%) to their portfolio in Q3 2025, for an estimated $79,549,046
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 5,150,000 shares (+247.3%) to their portfolio in Q3 2025, for an estimated $77,919,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
